WuXi AppTec Co. Ltd Cash Flow Conversion Efficiency

Latest as of March 2023: 0.061x

WuXi AppTec Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, WuXi AppTec Co. Ltd (WX8) has a cash flow conversion efficiency ratio of 0.061x as of March 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€3.03 Billion ≈ $3.54 Billion USD) by net assets (€49.83 Billion ≈ $58.26 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of WuXi AppTec Co. Ltd (2016–2025)

Cash flow conversion efficiency of WuXi AppTec Co. Ltd from 2016 to 2025. This chart illustrates how WuXi AppTec Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View WuXi AppTec Co. Ltd stock quote for real-time trading data and today's change.

WuXi AppTec Co. Ltd Cash Flow Conversion Ratio Explained

WuXi AppTec Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

WuXi AppTec Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of WuXi AppTec Co. Ltd ranked by their cash flow conversion efficiency. Also see WuXi AppTec Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
B3 S.A. UNSP.ADR/1
F:YBV0
0.085x
GJENSIDIGE FORSI.UNSP.ADR
F:XGJ0
N/A
The J. M. Smucker Company
NYSE:SJM
0.057x
Guangdong Haid Group Co Ltd
SHE:002311
0.080x
Piraeus Bank S.A.
NASDAQ:PIRBF
-0.331x
Zhejiang Nhu Co Ltd
SHE:002001
0.069x
Aeroports de Paris SA
PA:ADP
0.154x
ASAHI KASEI CORP. ADR/2
F:ASA
N/A

Annual Cash Flow Conversion Efficiency for WuXi AppTec Co. Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of WuXi AppTec Co. Ltd from 2016 to 2025. Review WX8 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €80.25 Billion
≈ $93.82 Billion
€17.20 Billion
≈ $20.11 Billion
0.214x +2.10%
2024-12-31 €59.09 Billion
≈ $69.08 Billion
€12.41 Billion
≈ $14.50 Billion
0.210x -12.92%
2023-12-31 €55.52 Billion
≈ $64.91 Billion
€13.39 Billion
≈ $15.65 Billion
0.241x +6.59%
2022-12-31 €46.93 Billion
≈ $54.86 Billion
€10.62 Billion
≈ $12.41 Billion
0.226x +91.05%
2021-12-31 €38.76 Billion
≈ $45.31 Billion
€4.59 Billion
≈ $5.37 Billion
0.118x -2.50%
2020-12-31 €32.72 Billion
≈ $38.25 Billion
€3.97 Billion
≈ $4.65 Billion
0.121x -27.49%
2019-12-31 €17.41 Billion
≈ $20.35 Billion
€2.92 Billion
≈ $3.41 Billion
0.167x +85.47%
2018-12-31 €18.17 Billion
≈ $21.24 Billion
€1.64 Billion
≈ $1.92 Billion
0.090x -66.08%
2017-12-31 €6.74 Billion
≈ $7.88 Billion
€1.79 Billion
≈ $2.10 Billion
0.266x -8.14%
2016-12-31 €6.06 Billion
≈ $7.09 Billion
€1.76 Billion
≈ $2.05 Billion
0.290x --

About WuXi AppTec Co. Ltd

F:WX8 Germany Diagnostics & Research
Market Cap
$11.75 Billion
€10.05 Billion EUR
Market Cap Rank
#1917 Global
#413 in Germany
Share Price
€19.69
Change (1 day)
-2.38%
52-Week Range
€10.60 - €25.00
All Time High
€25.00
About

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manuf… Read more